A detailed history of Huntington National Bank transactions in Glaukos Corp stock. As of the latest transaction made, Huntington National Bank holds 7 shares of GKOS stock, worth $954. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 7 -0.0%
Holding current value
$954
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$89.48 - $118.35 $536 - $710
6 Added 600.0%
7 $0
Q4 2022

Feb 09, 2023

SELL
$40.82 - $57.75 $10,205 - $14,437
-250 Reduced 99.6%
1 $0
Q2 2021

Jul 30, 2021

BUY
$73.06 - $97.7 $18,265 - $24,425
250 Added 25000.0%
251 $21,000
Q2 2019

Jul 23, 2019

BUY
$63.59 - $78.71 $63 - $78
1 New
1 $0
Q4 2017

Feb 02, 2018

SELL
$24.5 - $36.01 $6,762 - $9,938
-276 Closed
0 $0
Q3 2017

Oct 24, 2017

BUY
$31.26 - $42.03 $8,627 - $11,600
276
276 $9,000

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $6.49B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.